Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Sort 1 results by:

Filter Applied. Clear All

Latest Posts

April 14, 2026 Drug-induced Abortion After the First Trimester Drug-induced Abortion After the First Trimester April 10, 2026 Abortion Law in America Today: Confronting Infringements on Pro-life Laws Abortion Law in America Today: Confronting Infringements on Pro-life Laws April 9, 2026 New Study: Most Women Seeking Abortion Have Higher Risk of Negative Psychological Reactions New Study: Most Women Seeking Abortion Have Higher Risk of Negative Psychological Reactions
Reset All Filters
Life & the Law

Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case

CLI recently filed an amicus brief in the case Moyle v. United States (consolidated with Idaho v. U.S.) to be considered before the Supreme Court this April. The Biden administration has interpreted the federal Emergency Medical Treatment and Labor Act in a way that would compel emergency room doctors to perform abortions even when a mother’s life is not in danger. According to CLI, such an interpretation of EMTALA is incoherent and in conflict with the plain sense of the text.

Maternal & Public Health

Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data

The FDA’s abortion drugs complications data is woefully incomplete. From 2020-2022, the six states that report complications by type of procedure reported 1,004 total complications from drug-induced abortions. Meanwhile, the FDA Adverse Event Reporting System data reflects just 17 unduplicated abortion-related adverse events over this same period.

Life & the Law

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepristone is not "safe," that the FDA's loosening of mifepristone regulations makes these safety concerns even worse, and that AHM et al. have standing, since they would suffer concrete injury under the current loosened mifepristone regulations, being at risk of finding themselves complicit in abortion procedures.

Scientists to SCOTUS: FDA Harms Women & Doctors by Allowing Dangerous Mail-Order Abortion Drugs
Abortion Drugs

Scientists to SCOTUS: FDA Harms Women & Doctors by Allowing Dangerous Mail-Order Abortion Drugs

As the nation’s leading pro-life scientific, statistical and research center, the Charlotte Lozier Institute has filed an amicus brief asking the Supreme Court to affirm the 5th U.S. Circuit Court of Appeals decision that found the FDA likely violated the law when it loosened safeguards on abortion drugs by allowing them to be sent by mail.

Effects of prior reproductive losses on risk of cardiovascular diseases within six months of a first live birth
Maternal & Public Health

Effects of prior reproductive losses on risk of cardiovascular diseases within six months of a first live birth

There is emerging evidence suggesting that pregnancy loss (induced or natural) is associated with an increased risk of cardiovascular diseases (CVD). This prospective longitudinal study investigates the effect of prior pregnancy losses on CVD risk during the first six months following a first live birth.

Maternal & Public Health

Abortion Reporting: North Carolina (2022)

In 2022, there were 40,037 abortions reported in North Carolina, an increase of 23% from 2021.

Maternal & Public Health

Abortion Reporting: New York (2021)

New York’s 2021 abortion statistics were published online by the New York Department of Health in December 2022, showing that abortions performed on New York residents slightly increased from 2020.

Maternal & Public Health

Abortion Reporting: New York City (2021)

New York City’s 2021 abortion statistics showed a very slight increase in the number of abortions occurring from 2020 to 2021, with 37,813 abortions reported in the city in 2021, a 0.77% increase from 2020.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image